Genentech invests $400 million in Oregon

| Print |  Email
Articles - May 2010
Friday, April 16, 2010
starkmangovernor
Genentech’s Barry Starkman presents a T-shirt to Gov. Ted Kulongoski. Starkman oversees 250
employees at the company’s new Hillsboro facility.
OREGON BUSINESS PHOTO

Since purchasing 75 acres of land in Hillsboro in 2006, the San Francisco-based pharmaceutical giant Genentech has invested $400 million in Oregon and created 250 jobs at its new fill/finish and distribution facility. Plant manager Barry Starkman spoke with Oregon Business after a ribbon-cutting ceremony in early April.

Where are you from?
Originally, I’m from New Jersey. Spent most of my life there. Went to college in Pennsylvania, worked for a while there, then spent 24 years with Merck, working overseas in Belgium. I joined Genentech about five years ago.

You were involved with Genentech’s move to Oregon from the beginning?
I started working on this in the summer of 2005, about six months after I joined Genentech. For a while I was based out of San Francisco. We moved to Oregon in July of 2007.

Describe your experience expanding into Oregon.
It’s been an amazing experience. Oregon set itself apart from the other places we looked at. People were genuine about wanting us to be here. It wasn’t just a façade. It was real. They were looking to diversify the portfolio of businesses here and they were ready to take it all the way.

Did that change after you bought the property?
Not at all. Once we made the decision to come here, it didn’t stop. It was about everything they could do to bring this to reality. A friend of mine with another pharmaceutical company has been trying to do a similar project, and the last time I talked to him he still hadn’t gotten the money from the state. The promises still weren’t fulfilled. Here, every single promise was fulfilled.

Your experience seems to contradict the criticism the state has gotten lately for being anti-business.
I have not experienced that. I don’t know whether it’s something special in Hillsboro as opposed to different places, but I can tell you that my experience in Hillsboro has been extremely positive. Any time we ran into an issue during construction they were right there doing what they could.

What about the tax increases that just passed? How do they affect you?
From my vantage point of running this facility, it’s had no impact at all. There’s nothing that has or will change the course that we’re on. We are on track, and this facility is a key strategic component.

Are you happy with the job Hoffman Construction did?
We didn’t know anything about Hoffman. But they presented themselves extremely well. They had the contacts here, they had good relationships with the building trades council, and they delivered a beautiful building to us. It was different for us to do a design-build project, which we hadn’t done before. That was a little risky on our end, but the rewards have paid off. And we maintain a great relationship with them.

What about the 300 employees you’ll have when fully operational?
About half of our employees are transplants from California. The rest have been hired locally, or through national searches for specialized engineers. We also developed a program (with state funding) at Portland Community College and provided scholarships for the first two cohorts of students to go through it. They went for free, and out of those 40-plus students I think we hired 27.

Are these biotech jobs?
We’re proud to say we are part of the biotech process. It’s a vertically integrated process from end to end, and we’re the final step before the medicine goes to the patient.

Genentech is a perennial pick for Fortune’s 100 Best Companies to Work For. What puts the company on that list year after year?
There are a lot of things about Genentech that contribute to the culture. It’s the T-shirt and jeans culture we have, the great benefits we offer and the great salaries we pay people. It’s the bonuses and stock options all levels of employees get, whether you are sweeping the floor as a maintenance worker or the CEO... But the most important thing, and what attracted me here, is the energy around patients. A woman I know is a breast cancer patient, and she’s using Avastin [a tumor-starving cancer medication developed by Genentech] as part of the clinical trial. She was here the day we packaged Avastin for the first time. She spoke to our entire employee population about her experiences. That gives you a sense of purpose. It’s easy to get up to come to work here in the morning.

BEN JACKLET
 

More Articles

Growing a mobility cluster

News
Friday, October 31, 2014
0414 bikes bd2f6052BY LINDA BAKER | OB EDITOR

Why are there so few transportation startups in Portland?  The city’s leadership in bike, transit and pedestrian transportation has been well-documented.  But that was then — when government and nonprofits paved the way for a new, less auto centric way of life.


Read more...

The short list: 5 companies making a mint off kale

The Latest
Thursday, November 20, 2014
kale-thumbnailBY OB STAFF

Farmers, grocery stores and food processors cash in on kale.


Read more...

OB Poll: Wineries and groceries

News
Friday, October 24, 2014

24-winethumbA majority of respondents agreed: Local vineyards should remain Oregon-owned and quality is the most important factor when determining where to eat or buy groceries.


Read more...

Dan and Louis Oyster Bar opens up to a changing neighborhood

The Latest
Thursday, December 11, 2014
121114-oystervidBy MEGHAN NOLT

VIDEO: Revamping a Classic — an iconic eatery stays relevant in a changing marketplace.


Read more...

Powerbook Perspective

January-Powerbook 2015
Friday, December 12, 2014
BY LINDA BAKER

A conversation with Oregon state economist Josh Lehner.


Read more...

Corner Office: Sheree Arntson

January-Powerbook 2015
Saturday, December 13, 2014

Checking in with the managing director of Arnerich Massena.


Read more...

Streetfight

News
Sunday, December 07, 2014
BY LINDA BAKER

On Friday, Uber switched on an app — and with one push of the button torpedoed Portland’s famed public process.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS